D Seed Therapeutics Trademark Application - Class 042 Technology Services
Summary
The USPTO published a trademark application from D Seed Therapeutics for "D SEED THERAPEUTICS" covering Class 042 technology services including pharmaceutical research, drug discovery, and biotechnology services. The application (TM99361665) was filed on August 27, 2025, under Intent to Use provisions, with a publication date of April 1, 2026.
What changed
D Seed Therapeutics filed an Intent to Use trademark application (TM99361665) with the USPTO for "D SEED THERAPEUTICS" in Class 042. The application covers drug discovery, pharmaceutical research and development services, medical and scientific research consulting, and biotechnology services including ubiquitin ligase identification and protein labeling using photocatalyst molecules. The application was filed August 27, 2025, and published for opposition on April 1, 2026.
Competitors in the pharmaceutical and biotechnology sectors should review this application to assess potential conflicts with existing marks. Third parties have until the opposition deadline to file objections based on likelihood of confusion or other grounds. No immediate compliance actions are required for entities outside the pharmaceutical/biotech trademark space.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
D SEED THERAPEUTICS
Intent to Use TM99361665 Kind: intenttouse Apr 01, 2026
Abstract
drug discovery, development and validation services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical and medical research information via the internet; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; research and development of new products; scientific, medical and clinical research and development services; providing information, scientific, pharmaceutical, clinical, and medical research, drug discovery, development and validation, and consulting services with respect to identifying ubiquitin ligases; providing information, scientific, pharmaceutical, clinical and medical research, drug discovery, development and validation, and consulting services with respect to using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell
Filing Date
2025-08-27
Related changes
Get daily alerts for USPTO Trademarks - Technology Services (Class 042)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Technology Services (Class 042) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.